Navigation Links
Stemedica Completes Meeting with the FDA
Date:10/15/2009

Nikolai Tankovich, MD, PhD, Stemedica's President and Chief Medical Officer. "In addition to the official licensing of our manufacturing facility in San Diego, California, we can now establish our own clinical trial pathways for our various products. Stemedica's goal is to receive regulatory approvals for the clinical application of all of its products."

"With constructive feedback from the FDA we can work on fine-tuning the proposed treatment protocol and advance our proposed clinical trial to targeted medical facilities for full consideration," said Michael Levy, MD, PhD. Dr. Levy is the Chief of Pediatric Neurosurgery, Rady Children's Hospital of San Diego, Professor of Surgery, UCSD School of Medicine and the Principal Investigator for the proposed clinical trial.

Stemedica was granted its license by the State of California's Department of Public Health, Food and Drug Branch to manufacture stem cells for clinical trials in July, 2009. The Drug Manufacturing License grants Stemedica the right to manufacture clinical-grade (for human use) drug or biologic products and recognizes Stemedica as being compliant with California law and the applicable provisions of the Code of Federal Regulations.

About Stemedica Cell Technologies, Inc.
Stemedica Cell Technologies Inc. (www.stemedica.com) is a specialty biopharmaceutical company that is committed to the development and manufacturing of best-in-class adult stem cells and stem cell factors for use by approved research institutions and hospitals for pre-clinical and human clinical trials. The company is currently developing regulatory pathways for stroke and wound repair. Stemedica is headquartered in San Diego, Ca
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

0

GOOD

Page: 1 2 3

Related biology technology :

1. United States Patent and Trademark Office Publishes Stemedica's Patent Application for the Treatment of Diabetic Retinopathy
2. The Jordanian Stem Cell Company Acquires Stem Cell Technology From Stemedica International S.A. - First Clinical Trail Anticipated To Begin Early 2010
3. Stemedica Achieves Major Milestone - Company Receives License to Manufacture Clinical Grade Stem Cells
4. Stemedica Selected By World Stem Cell Summit To Present Scientific Discoveries
5. Stemedica Requests Pre-IND Meeting With FDA
6. Stemedica Signs Scientific Advisory Board Agreement with Leading Pediatric Burn & Wound Care Researcher
7. Renowned Stem Cell Researcher Files Study Results With Stemedica
8. CIRM Completes Briefing Visit to Stemedica Cell Technologies
9. Stemedica Announces the Appointment of Dr. Michael Bayer as Director, Medical Services
10. Ipsen and Debiopharm Group Announce That Decapeptyl(R)(triptorelin embonate) 6-month Successfully Completes the European Decentralised Procedure for the Treatment of Locally Advanced or Metastatic Prostate Cancer
11. Jennerex Completes Over-Subscribed Series C Financing for Aggregate Gross Proceeds of Over $5.5 Million
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Stemedica Completes Meeting with the FDA
Stemedica Completes Meeting with the FDA
(Date:12/15/2009)... China Sky One,Medical, Inc. ("China Sky One Medical" ... fully integrated pharmaceutical company developing and producing,over-the-counter drugs ... that the Company has 30 medicines that will ... Basic Medical Insurance, Industrial Injury Insurance,and Maternity Insurance ... 30 medicines treat a variety of common ailments ...
(Date:12/15/2009)... Va., Dec. 15 AstraZeneca (NYSE: ... of Virginia (UVa) in Charlottesville, today announced ... research collaboration to enhance development of new ... with a secondary focus on peripheral vascular ... ) ,, The collaborative preclinical research projects ...
(Date:12/15/2009)... N.Y., Dec. 15 The International Society ... the professional society is continuing to accept abstracts ... held in Arlington, VA, April 19-21, 2010. This ... encouraging non-members to join the organization to submit ... submission deadline is 12 AM EST, January 15, ...
(Date:12/15/2009)... and LONDON, Dec. 15 ... Thomson Pharma ® has become the first drug ... protocol and outcome information. This highly anticipated new ... customers this month. ,, Thomson ... intelligence from registries, publications, press releases, conferences, and ...
Breaking Biology Technology:China Sky Medical, Inc. Has 30 Medicines that will Be Included in China's National Insurance Directory 2China Sky Medical, Inc. Has 30 Medicines that will Be Included in China's National Insurance Directory 3AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 2AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 3The International Society for Medical Publication Professionals Announces Call for Abstracts for Its 6th Annual Meeting 2The International Society for Medical Publication Professionals Announces Call for Abstracts for Its 6th Annual Meeting 3Thomson Reuters is First to Offer Fully Integrated Pipeline and Clinical Trials 2
... Eppendorf Perfectprep Gel Cleanup Kit , , ... Cleanup Kit , , , , , ... 5 Prime, Inc. , October 1, 2002, , , ... Agarose gel electrophoresis is a method used to separate and analyze , ...
... , , , , ... Comments , Microinjection is the loading or transfer of ... tip of the glass microcapillary , has an inner diameter ... back loaded with the substance to be transferred into the cells , ...
... , , , , , ... quantitative analysis of nucleic acids , and proteins has ... It includes absorption measurements in the ultraviolet and in the visibility , ... at 260 , nm and colorimetric protein determination is ...
Other Biology Technology:Eppendorf Perfectprep Gel Cleanup Kit 2Eppendorf Perfectprep Gel Cleanup Kit 3Eppendorf Perfectprep Gel Cleanup Kit 4Eppendorf Perfectprep Gel Cleanup Kit 5Eppendorf Perfectprep Gel Cleanup Kit 6Sample Preparation for Microinjection 2Sample Preparation for Microinjection 3Sample Preparation for Microinjection 4Sample Preparation for Microinjection 5Sample Preparation for Microinjection 6Sample Preparation for Microinjection 7Quantification made easy 2Quantification made easy 3
(Date:12/16/2009)... 8, 2009 National Instruments (Nasdaq: ... measurement and control, and DENSO Robotics, a ... robotics technology, today announced their collaboration to ... DENSO robotic arms. The collaboration increases productivity ... flexible manufacturing applications. In today,s trend toward ...
(Date:12/15/2009)... COLUMBIA, Mo. As soon as babies are ... as jaundice and e-coli. For up to a month, ... Although these infections are often minor, they can lead ... newborns, immune systems, University of Missouri researchers have pinpointed ... lead to an immune-strengthening vaccine. , "We,re trying to ...
(Date:12/15/2009)... VIB and Ghent University in Flanders, Belgium have found ... the major cause of death in intensive care units. ... in mice with septic shock, researchers Anje Cauwels and ... less damage, while their chances of survival increased significantly. ... assumed that nitric oxide is responsible for the potentially ...
Breaking Biology News(10 mins):National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 2National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 3National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 4National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 5Researchers work on vaccine to improve immune system in newborns 2Septic shock: Nitric oxide beneficial after all 2Boston Scientific to Participate in Morgan Stanley Global Healthcare Conference 56822 1Boston Scientific to Participate in Morgan Stanley Global Healthcare Conference 56822 2NorthShore University HealthSystem First in Illinois to Perform Remarkable Robotic Arm Guided Partial Knee Replacement Surgery 56819 1NorthShore University HealthSystem First in Illinois to Perform Remarkable Robotic Arm Guided Partial Knee Replacement Surgery 56819 2NorthShore University HealthSystem First in Illinois to Perform Remarkable Robotic Arm Guided Partial Knee Replacement Surgery 56819 3NorthShore University HealthSystem First in Illinois to Perform Remarkable Robotic Arm Guided Partial Knee Replacement Surgery 56819 4Regions Hospital Selected to Participate in National Cardiac Care Quality Improvement Effort 56815 1Regions Hospital Selected to Participate in National Cardiac Care Quality Improvement Effort 56815 2Regions Hospital Selected to Participate in National Cardiac Care Quality Improvement Effort 56815 3
... an observational study by researchers at the University of ... and 80 years of age who received treatment for ... men who did not receive treatment. The study will ... Journal of the American Medical Association. , Thanks to ...
... cases, scientists at Johns Hopkins have discovered the genetic origins ... the leading reason for corneal transplantation in the United States. ... the cells covering the clear, outermost lens of the eye ... Late in life, the dystrophy causes swelling of the cornea ...
... efficient propulsion of squid, jellyfish and other cephalopods, a ... new generation of compact vortex generators that could make ... vehicles at low speeds and with greater precision. , ... plots of two classic sci-fi films - may soon ...
Other Biology News:Older men treated for early prostate cancer live longer than those who are not 2Leading reason for corneal transplants comes into focus 2Leading reason for corneal transplants comes into focus 3Squid-inspired design could mean better handling of underwater vehicles 2
... for the synthesis of 5' capped RNA ... of cap analog for a large portion ... transcription reaction results in the incorporation of ... of the transcripts. Capped mRNAs are generally ...
... The iEMS Incubator/Shaker HT is ... the iEMS Incubator/Shaker HT is ... DNA hybridization and primer extension ... is available as a one-cabinet ...
... iEMS Incubator/Shaker HT is designed ... iEMS Incubator/Shaker HT is ideal ... hybridization and primer extension assays. ... as a one-cabinet model, allowing ...
... Pseudomonas atlantica Description: Beta-Agarase is useful ... from low-melting-temperature agarose. Beta-Agarase digests the ... User Friendly Properties: Heat Inactivation: 65C, ... Optimum pH: 6.5 Purity: Tested for ...
Biology Products: